Jeffrey M. Friedman

From WikiMD's Food, Medicine & Wellness Encyclopedia

Jeffrey M. Friedman is an American molecular geneticist renowned for his discovery of leptin, a hormone that regulates appetite and body weight. This groundbreaking work has significantly advanced our understanding of obesity, metabolism, and the complex mechanisms controlling body weight and energy balance.

Early Life and Education[edit | edit source]

Jeffrey M. Friedman was born in 1954 in Orlando, Florida. He developed an interest in science and biology at a young age, which led him to pursue an undergraduate degree in biology from Rensselaer Polytechnic Institute. After completing his bachelor's degree, Friedman went on to earn his M.D. from Albany Medical College and later received a Ph.D. in Molecular Genetics from the Rockefeller University, where he studied under the tutelage of notable scientists such as James Darnell.

Career and Research[edit | edit source]

After completing his education, Friedman joined the faculty at the Rockefeller University, where he has spent the majority of his career. His research initially focused on the genetics of obesity, a condition that affects millions worldwide and is associated with numerous health problems, including diabetes, heart disease, and hypertension.

In 1994, Friedman's lab made a landmark discovery by identifying and cloning the gene that codes for leptin, a hormone produced by fat cells that signals the brain to regulate food intake and energy expenditure. This discovery was pivotal, as it provided the first genetic evidence that body weight is regulated by specific biological pathways. Following this discovery, Friedman and his team further elucidated the role of leptin in obesity and related metabolic disorders, uncovering how mutations in the leptin gene or its receptor can lead to obesity in humans and animals.

Impact and Recognition[edit | edit source]

Friedman's work on leptin has had a profound impact on the field of obesity research and has opened new avenues for the development of treatments for obesity and metabolic diseases. His contributions have been recognized with numerous awards and honors, including the Lasker Award for Basic Medical Research and the Gairdner Foundation International Award. He is a member of the National Academy of Sciences and the American Academy of Arts and Sciences.

Current Work[edit | edit source]

As of the last update, Jeffrey M. Friedman continues his research at the Rockefeller University, focusing on the genetic and neural networks that regulate appetite and body weight. His ongoing work aims to further unravel the complex interactions between genetics, metabolism, and behavior that contribute to obesity and related conditions.

Legacy[edit | edit source]

Jeffrey M. Friedman's discovery of leptin has been a cornerstone in the field of endocrinology and metabolism, providing a molecular basis for understanding obesity and paving the way for potential therapeutic strategies targeting leptin and its pathways. His work exemplifies the power of genetic and molecular approaches to solving complex biological problems and has had a lasting impact on both science and medicine.


Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD